Related Experiment Videos
Fatal cardiac arrhythmia after oral sumatriptan
K Laine1, T Raasakka, J Mäntynen
1Department of Pharmacology and Clinical Pharmacology, University of Turku, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.
Headache
|March 31, 2001
Summary
Sumatriptan can cause chest discomfort in 3-5% of patients, but serious cardiovascular events are rare. This case highlights a fatal cardiac arrhythmia in a healthy migraine patient after oral sumatriptan.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Sumatriptan is a widely used medication for acute migraine treatment.
- Adverse cardiovascular events are infrequently reported with sumatriptan, primarily linked to its subcutaneous form or pre-existing cardiovascular risk factors.
Observation:
- A single 100-mg oral dose of sumatriptan was administered to a patient with a history of migraine.
- The patient was otherwise healthy with no known cardiovascular risk factors.
Findings:
- The patient experienced a fatal cardiac arrhythmia shortly after sumatriptan ingestion.
- This event occurred despite the oral dosage form and the absence of underlying cardiovascular disease.
Implications:
- This case underscores the potential for serious, albeit rare, cardiovascular adverse events with oral sumatriptan, even in healthy individuals.
- It suggests a need for continued vigilance regarding sumatriptan's cardiovascular safety profile.
- Further investigation into the mechanisms of oral sumatriptan-induced arrhythmias may be warranted.